{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:39:19Z","timestamp":1789961959381,"version":"4.0.1"},"reference-count":268,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>New anticancer therapeutic strategies, including targeting of iron dysregulation in affected cancer types and stages, are urgently needed to decrease the associated annual cancer death rate of about 10 million worldwide. Many tumours evade treatment and support metastatic potential by effluxing iron and upregulating antioxidant systems, leading to suppression of lipid peroxidation and ferroptotic cell death. Similarly, many tumours manipulate the tumour microenvironment (TME) by ensuring the continuous supply of iron. This involves phenotypic modulation of immune cells, including macrophages, neutrophils, regulatory T lymphocytes, and natural killer cells, as well as fibroblasts, contributing to immune evasion and tumour growth. In particular, tumour-associated macrophages (TAMs), which may account for about half of the tumour\u2019s bulk, become progressively heavily loaded with iron and can be detected by magnetic resonance imaging (MRI) technologies. Clinically effective iron chelation therapy protocols in iron-overloaded conditions using the chelating drugs deferoxamine, deferasirox, and especially deferiprone can also potentially remove excess iron from TAMs and may decrease tumour malignancy. Deferiprone can also remove excess iron from iron-loaded renal cancer cells and potentially prevent metastasis in renal carcinoma. The anticancer potential of deferiprone has also been shown in other cancers, including iron removal in prostate cancer and through cancer stem cell inhibition in breast cancer. Many ongoing clinical trials using different drugs and experimental agents for inducing or modulating ferroptosis also support the translational potential of ferroptosis-based therapeutic strategies in selected categories of cancer patients. These advances highlight ferroptosis as a potential key metabolic vulnerability with relevance for treatment-resistant and metastatic tumours. Overall, iron chelation therapeutic approaches and ferroptosis-targeting may be considered for significant use as monotherapies or in combination with other anticancer drugs and could potentially improve therapeutic outcomes and limit disease progression and mortality in many cancers.<\/jats:p>","DOI":"10.3390\/cancers18091436","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:20:25Z","timestamp":1777551625000},"page":"1436","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Linking Iron Metabolism, Ferroptosis, and Cancer: New Targets and Prospects for Effective Anticancer Therapeutic Interventions"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4176-8425","authenticated-orcid":false,"given":"Malamati","family":"Kourti","sequence":"first","affiliation":[{"name":"Postgraduate Research Institute of Science, Technology, Environment and Medicine, 3021 Limassol, Cyprus"},{"name":"Department of Life Sciences, European University Cyprus, 2404 Nicosia, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3364-7340","authenticated-orcid":false,"given":"George J.","family":"Kontoghiorghes","sequence":"additional","affiliation":[{"name":"Postgraduate Research Institute of Science, Technology, Environment and Medicine, 3021 Limassol, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer Statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin. Med. J."},{"key":"ref_3","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/cncr.35458","article-title":"Burden of 30 Cancers among Men: Global Statistics in 2022 and Projections for 2050 Using Population-based Estimates","volume":"130","author":"Bizuayehu","year":"2024","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S1470-2045(25)00730-2","article-title":"Global, Regional, and National Burden of Breast Cancer among Females, 1990\u20132023, with Forecasts to 2050: A Systematic Analysis for the Global Burden of Disease Study 2023","volume":"27","author":"Bhangdia","year":"2026","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Bukowski, K., Kciuk, M., and Kontek, R. (2020). Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21093233"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40880-017-0219-2","article-title":"Autophagy and Multidrug Resistance in Cancer","volume":"36","author":"Li","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Said, S.S., and Ibrahim, W.N. (2023). Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041143"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1080\/10717544.2022.2079771","article-title":"Recent Advances in Anti-Multidrug Resistance for Nano-Drug Delivery System","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.phrs.2017.07.023","article-title":"MDR in Cancer: Addressing the Underlying Cellular Alterations with the Use of Nanocarriers","volume":"126","author":"Singh","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s44276-024-00064-8","article-title":"New Light on Chemotherapy Toxicity and Its Prevention","volume":"2","author":"Juthani","year":"2024","journal-title":"BJC Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Basak, D., Arrighi, S., Darwiche, Y., and Deb, S. (2021). Comparison of Anticancer Drug Toxicities: Paradigm Shift in Adverse Effect Profile. Life, 12.","DOI":"10.3390\/life12010048"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/annonc\/mds027","article-title":"Risk of Serious Toxicity in 1181 Patients Treated in Phase I Clinical Trials of Predominantly Targeted Anticancer Drugs: The M. D. Anderson Cancer Center Experience","volume":"23","author":"Wheler","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.3390\/curroncol30100665","article-title":"Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors","volume":"30","author":"Lee","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1158\/0008-5472.CAN-19-0458","article-title":"Defining the Hallmarks of Metastasis","volume":"79","author":"Welch","year":"2019","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ng1060","article-title":"A Molecular Signature of Metastasis in Primary Solid Tumors","volume":"33","author":"Ramaswamy","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1038\/s41467-024-45307-x","article-title":"Causes of Death among People Living with Metastatic Cancer","volume":"15","author":"Mani","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41392-025-02148-4","article-title":"Invasion and Metastasis in Cancer: Molecular Insights and Therapeutic Targets","volume":"10","author":"Li","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","article-title":"Targeting Metastatic Cancer","volume":"27","author":"Ganesh","year":"2021","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/mco2.100","article-title":"Tumor Metastasis: Mechanistic Insights and Therapeutic Interventions","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2022). New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232213990"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Kourti, M., and Kontoghiorghes, G.J. (2025). Targeting Aging and Diseases Associated with Ferroptosis and Senescence Through Modulation of Iron, Oxidative Stress and Lipid Peroxidation. Antioxidants, 15.","DOI":"10.3390\/antiox15010015"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, K., Jiang, N., Chen, Z., Sun, X., Zha, H., Lin, M., Li, J., Pan, X., and Chen, J. (2026). Iron-Fueled Ferroptosis: A New Axis for Immunomodulation to Overcome Cancer Drug Resistance\u2014From Immune Microenvironment Crosstalk to Therapeutic Translation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1726210"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zeidan, R.S., Yoon, H.-S., Yang, J.J., Sobh, A., Braithwaite, D., Mankowski, R., Leeuwenburgh, C., and Anton, S. (2024). Iron and Cancer: Overview of the Evidence from Population-Based Studies. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1393195"},{"key":"ref_25","first-page":"153","article-title":"Iron Overload and Its Association with Cancer Risk in Humans: Evidence for Iron as a Carcinogenic Metal","volume":"533","author":"Huang","year":"2003","journal-title":"Mutat. Res.-Fundam. Mol. Mech. Mutagen."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","article-title":"Iron and Cancer","volume":"38","author":"Torti","year":"2018","journal-title":"Annu. Rev. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Hsu, M.Y., Mina, E., Roetto, A., and Porporato, P.E. (2020). Iron: An Essential Element of Cancer Metabolism. Cells, 9.","DOI":"10.3390\/cells9122591"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"\u0141\u0119cka, M., S\u0142omka, A., Albrecht, K., Romiszewski, M., and Styczy\u0144ski, J. (2025). Iron Dysregulation Signature in Pediatric Leukemia: In-Depth Biomarkers of Iron Metabolism Involving Matriptase-2 and Neogenin-1. Cancers, 17.","DOI":"10.3390\/cancers17152495"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1517\/14740330903535845","article-title":"Safety Issues of Iron Chelation Therapy in Patients with Normal Range Iron Stores Including Thalassaemia, Neurodegenerative, Renal and Infectious Diseases","volume":"9","author":"Kontoghiorghes","year":"2010","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/17474086.2020.1719359","article-title":"How to Manage Iron Toxicity in Post-Allogeneic Hematopoietic Stem Cell Transplantation?","volume":"13","author":"Kontoghiorghes","year":"2020","journal-title":"Expert Rev. Hematol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3109\/03630260903217182","article-title":"A New Era in Iron Chelation Therapy: The Design of Optimal, Individually Adjusted Iron Chelation Therapies for the Complete Removal of Iron Overload in Thalassemia and Other Chronically Transfused Patients","volume":"33","author":"Kontoghiorghes","year":"2009","journal-title":"Hemoglobin"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Brown, R.A.M., Richardson, K.L., Kabir, T.D., Trinder, D., Ganss, R., and Leedman, P.J. (2020). Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.00476"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lin, L., Yin, X., and Guan, Y. (2025). Decoding Iron Deficiency in Cancer: Mechanisms, Immune Modulation, and Therapeutic Potential. Front. Nutr., 12.","DOI":"10.3389\/fnut.2025.1650929"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-025-00595-w","article-title":"Iron and Metabolic Rewiring in Cancer","volume":"15","author":"Ciscar","year":"2026","journal-title":"Oncogenesis"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Glabman, R.A., Choyke, P.L., and Sato, N. (2022). Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy. Cancers, 14.","DOI":"10.3390\/cancers14163906"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sacco, A., Battaglia, A.M., Botta, C., Aversa, I., Mancuso, S., Costanzo, F., and Biamonte, F. (2021). Iron Metabolism in the Tumor Microenvironment\u2014Implications for Anti-Cancer Immune Response. Cells, 10.","DOI":"10.3390\/cells10020303"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Justus, C.R., Dong, L., and Yang, L.V. (2013). Acidic Tumor Microenvironment and PH-Sensing G Protein-Coupled Receptors. Front. Physiol., 4.","DOI":"10.3389\/fphys.2013.00354"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting Ferroptosis as a Vulnerability in Cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41419-022-04927-1","article-title":"Regulatory Pathways and Drugs Associated with Ferroptosis in Tumors","volume":"13","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_40","first-page":"1704","article-title":"A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy","volume":"18","author":"Wang","year":"2022","journal-title":"Small"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis Is an Autophagic Cell Death Process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3349\/ymj.2024.0210","article-title":"Acidic Tumor Microenvironments and Emerging Therapeutic Strategies for Cancer Therapy","volume":"66","author":"Zhuang","year":"2025","journal-title":"Yonsei Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bogdanov, A., Bogdanov, A., Chubenko, V., Volkov, N., Moiseenko, F., and Moiseyenko, V. (2022). Tumor Acidity: From Hallmark of Cancer to Target of Treatment. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.979154"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1517\/13543784.2013.787408","article-title":"Potential Clinical Applications of Chelating Drugs in Diseases Targeting Transferrin-Bound Iron and Other Metals","volume":"22","author":"Kontoghiorghe","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ccell.2019.02.009","article-title":"Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets","volume":"35","author":"Cassetta","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.cell.2017.04.016","article-title":"An Immune Atlas of Clear Cell Renal Cell Carcinoma","volume":"169","author":"Chevrier","year":"2017","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","article-title":"A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer","volume":"177","author":"Wagner","year":"2019","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"14293","DOI":"10.1038\/ncomms14293","article-title":"Heterogeneity of Macrophage Infiltration and Therapeutic Response in Lung Carcinoma Revealed by 3D Organ Imaging","volume":"8","author":"Cuccarese","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612928"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3324\/haematol.2010.030239","article-title":"Control of Iron Homeostasis as a Key Component of Macrophage Polarization","volume":"95","author":"Gaetano","year":"2010","journal-title":"Haematologica"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1182\/blood.2022015596","article-title":"Hemolysis, Free Hemoglobin Toxicity, and Scavenger Protein Therapeutics","volume":"140","author":"Vallelian","year":"2022","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1100\/2011\/213962","article-title":"Macrophage Polarization in Health and Disease","volume":"11","author":"Cassetta","year":"2011","journal-title":"Sci. World J."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"P\u00e9rez, S., and Rius-P\u00e9rez, S. (2022). Macrophage Polarization and Reprogramming in Acute Inflammation: A Redox Perspective. Antioxidants, 11.","DOI":"10.3390\/antiox11071394"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/eji.200939889","article-title":"Differential Regulation of Iron Homeostasis during Human Macrophage Polarized Activation","volume":"40","author":"Recalcati","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43ra56","DOI":"10.1126\/scitranslmed.3001127","article-title":"Ferroportin and Iron Regulation in Breast Cancer Progression and Prognosis","volume":"2","author":"Pinnix","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115647","DOI":"10.1016\/j.intimp.2025.115647","article-title":"Ferroptosis as a Precise Target for Tumor-Associated Neutrophils: From Molecular Insights to Targeted Therapies","volume":"167","author":"Zhao","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00262-024-03894-0","article-title":"Transferrin Receptor Uptakes Iron from Tumor-Associated Neutrophils to Regulate Invasion Patterns of OSCC","volume":"74","author":"Si","year":"2025","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Liang, W., and Ferrara, N. (2021). Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.626812"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Ni, S., Yuan, Y., Kuang, Y., and Li, X. (2022). Iron Metabolism and Immune Regulation. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.816282"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41392-025-02242-7","article-title":"Therapeutic Potential of Tumor-Associated Neutrophils: Dual Role and Phenotypic Plasticity","volume":"10","author":"Zhou","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Mukaida, N., Sasaki, S., and Baba, T. (2020). Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103457"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1073\/pnas.1811717115","article-title":"Metastatic Growth Instructed by Neutrophil-Derived Transferrin","volume":"115","author":"Liang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101915","DOI":"10.1016\/j.xcrm.2024.101915","article-title":"Dual Ferroptosis Induction in N2-TANs and TNBC Cells via FTH1 Targeting: A Therapeutic Strategy for Triple-Negative Breast Cancer","volume":"6","author":"Liu","year":"2025","journal-title":"Cell Rep. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s44318-024-00064-x","article-title":"Ferritin Heavy Chain Supports Stability and Function of the Regulatory T Cell Lineage","volume":"43","author":"Wu","year":"2024","journal-title":"EMBO J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.oooo.2025.09.012","article-title":"Tumor Potential Biomarker: Ferritin Heavy Chain Promotes Proliferation and Migration of Oral Squamous Cell Carcinoma","volume":"141","author":"Huang","year":"2026","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.18632\/aging.202841","article-title":"Comprehensive Analysis of Ferritin Subunits Expression and Positive Correlations with Tumor-Associated Macrophages and T Regulatory Cells Infiltration in Most Solid Tumors","volume":"13","author":"Hu","year":"2021","journal-title":"Aging"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/s41419-024-06976-0","article-title":"Natural Killer Cells at the Frontline in the Fight against Cancer","volume":"15","author":"Geindreau","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1002\/mco2.626","article-title":"Natural Killer Cells in Cancer Immunotherapy","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jiang, P., Jing, S., Sheng, G., and Jia, F. (2024). The Basic Biology of NK Cells and Its Application in Tumor Immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1420205"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"102923","DOI":"10.1016\/j.redox.2023.102923","article-title":"Cancer-Associated Fibroblasts Impair the Cytotoxic Function of NK Cells in Gastric Cancer by Inducing Ferroptosis via Iron Regulation","volume":"67","author":"Yao","year":"2023","journal-title":"Redox Biol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Sottile, R., Federico, G., Garofalo, C., Tallerico, R., Faniello, M.C., Quaresima, B., Cristiani, C.M., Di Sanzo, M., Cuda, G., and Ventura, V. (2019). Iron and Ferritin Modulate MHC Class I Expression and NK Cell Recognition. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.00224"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-023-00142-2","article-title":"The Mechanism of Ferroptosis and Its Related Diseases","volume":"4","author":"Feng","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2020.02.027","article-title":"Lipid Peroxidation and Ferroptosis: The Role of GSH and GPx4","volume":"152","author":"Ursini","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"32433","DOI":"10.1073\/pnas.2006828117","article-title":"Polyunsaturated Fatty Acid Biosynthesis Pathway Determines Ferroptosis Sensitivity in Gastric Cancer","volume":"117","author":"Lee","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40170-020-00217-6","article-title":"Therapy-Induced Lipid Uptake and Remodeling Underpin Ferroptosis Hypersensitivity in Prostate Cancer","volume":"8","author":"Tousignant","year":"2020","journal-title":"Cancer Metab."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00018-025-05982-5","article-title":"Ferroptosis and Cancer: When Iron Turns against Tumors","volume":"83","author":"Toyokuni","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zhao, X., Li, X., and Xu, Y. (2024). Ferroptosis: A Dual-Edged Sword in Tumour Growth. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1330910"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Chen, S., Ma, J., Tang, J., Yang, Y., Zhou, S., and Feng, P. (2025). Research Progress of Macrophage Ferroptosis in Inflammatory Bowel Disease and Inflammation-Cancer Transformation. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1658280"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"112366","DOI":"10.1016\/j.cellsig.2026.112366","article-title":"Annexin A5 Ameliorates Immune-Mediated Liver Injury by Regulating Ferritinophagy\u2013Ferroptosis in M2 Macrophages via the NRF2\/ERK Pathway","volume":"141","author":"Li","year":"2026","journal-title":"Cell. Signal."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10495-025-02247-1","article-title":"Macrophage Ferroptosis in Hematologic Malignancies: Emerging Mechanisms and Therapeutic Implications","volume":"31","author":"Zhou","year":"2026","journal-title":"Apoptosis"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Greene, C.J., Attwood, K., Sharma, N.J., Balderman, B., Deng, R., Muhitch, J.B., Smith, G.J., Gross, K.W., Xu, B., and Kauffman, E.C. (2022). Iron Accumulation Typifies Renal Cell Carcinoma Tumorigenesis but Abates with Pathological Progression, Sarcomatoid Dedifferentiation, and Metastasis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.923043"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2018.12.013","article-title":"Suppressive Effects of Iron Chelation in Clear Cell Renal Cell Carcinoma and Their Dependency on VHL Inactivation","volume":"133","author":"Greene","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Schnetz, M., Meier, J.K., Rehwald, C., Mertens, C., Urbschat, A., Tomat, E., Akam, E.A., Baer, P., Roos, F.C., and Br\u00fcne, B. (2020). The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth. Cancers, 12.","DOI":"10.3390\/cancers12030530"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum Ferritin Is Derived Primarily from Macrophages through a Nonclassical Secretory Pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1039\/C3MT00347G","article-title":"Serum Ferritin Is an Important Inflammatory Disease Marker, as It Is Mainly a Leakage Product from Damaged Cells","volume":"6","author":"Kell","year":"2014","journal-title":"Metallomics"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/03630260600642542","article-title":"Low Serum Ferritin Levels Are Misleading for Detecting Cardiac Iron Overload and Increase the Risk of Cardiomyopathy in Thalassemia Patients. The Importance of Cardiac Iron Overload Monitoring Using Magnetic Resonance Imaging T2 and T2*","volume":"30","author":"Kolnagou","year":"2006","journal-title":"Hemoglobin"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Wang, J., An, W., Pang, Z., Zhao, M., Xu, A., and Zhao, J. (2025). The TFRC as a Prognostic Biomarker and Potential Therapeutic Target in Cervical Cancer: A Preliminary Study. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1523137"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/03630260701727119","article-title":"Chelators Controlling Metal Metabolism and Toxicity Pathways: Applications in Cancer Prevention, Diagnosis and Treatment","volume":"32","author":"Kontoghiorghes","year":"2008","journal-title":"Hemoglobin"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Fontana, F., Esser, A.K., Egbulefu, C., Karmakar, P., Su, X., Allen, J.S., Xu, Y., Davis, J.L., Gabay, A., and Xiang, J. (2023). Transferrin Receptor in Primary and Metastatic Breast Cancer: Evaluation of Expression and Experimental Modulation to Improve Molecular Targeting. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0293700"},{"key":"ref_91","first-page":"916","article-title":"Transferrin Receptor 1 in Cancer: A New Sight for Cancer Therapy","volume":"8","author":"Shen","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1158\/1541-7786.MCR-14-0074","article-title":"Altered Endosome Biogenesis in Prostate Cancer Has Biomarker Potential","volume":"12","author":"Johnson","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41591-026-04284-y","article-title":"Antibiotic Use and Gut Microbiome Composition Links from Individual-Level Prescription Data of 14,979 Individuals","volume":"32","author":"Baldanzi","year":"2026","journal-title":"Nat. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S2213-2600(20)30052-7","article-title":"Decreasing Antibiotic Use, the Gut Microbiota, and Asthma Incidence in Children: Evidence from Population-Based and Prospective Cohort Studies","volume":"8","author":"Patrick","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of Deaths from Cancer Caused by Metastases?","volume":"8","author":"Rogers","year":"2019","journal-title":"Cancer Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/0008-5472.CAN-15-1208","article-title":"Immunotargeting of Antigen XCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer","volume":"76","author":"Lanzardo","year":"2016","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e1408746","DOI":"10.1080\/2162402X.2017.1408746","article-title":"A Virus-Like-Particle Immunotherapy Targeting Epitope-Specific Anti-XCT Expressed on Cancer Stem Cell Inhibits the Progression of Metastatic Cancer In Vivo","volume":"7","author":"Bolli","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"21916","DOI":"10.1038\/s41598-023-49136-8","article-title":"Gankyrin Inhibits Ferroptosis through the P53\/SLC7A11\/GPX4 Axis in Triple-Negative Breast Cancer Cells","volume":"13","author":"Lei","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1038\/s41467-023-39401-9","article-title":"SLC7A11 Expression Level Dictates Differential Responses to Oxidative Stress in Cancer Cells","volume":"14","author":"Yan","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"111760","DOI":"10.1016\/j.cellsig.2025.111760","article-title":"Apatinib Combined with Paclitaxel Suppresses Synergistically TNBC Progression through Enhancing Ferroptosis Susceptibility Regulated SLC7A11\/GPX4\/ACSL4 Axis","volume":"131","author":"Ma","year":"2025","journal-title":"Cell. Signal."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e1494108","DOI":"10.1080\/2162402X.2018.1494108","article-title":"Bovine Herpesvirus 4-Based Vector Delivering the Full Length XCT DNA Efficiently Protects Mice from Mammary Cancer Metastases by Targeting Cancer Stem Cells","volume":"7","author":"Donofrio","year":"2018","journal-title":"Oncoimmunology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13058-025-02115-5","article-title":"Glutamine Synthetase Shields Triple-Negative Breast Cancer Cells from Ferroptosis in Metastasis Triggered by Glutamine Deprivation","volume":"27","author":"Yang","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e70131","DOI":"10.1002\/ctm2.70131","article-title":"Microenvironmental G Protein-coupled Estrogen Receptor-mediated Glutamine Metabolic Coupling between Cancer-associated Fibroblasts and Triple-negative Breast Cancer Cells Governs Tumour Progression","volume":"14","author":"He","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1007\/s00210-024-03488-8","article-title":"Cancer-Associated Fibroblast-Secreted Exosomal MiR-454-3p Inhibits Lipid Metabolism and Ferroptosis in Breast Cancer by Targeting ACSL4","volume":"398","author":"Gao","year":"2025","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal Cells in Tumor Microenvironment and Breast Cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Leonteva, A., Kazakova, A., Berezutskaya, E., Ilyina, A., Sergeevichev, D., Vladimirov, S., Bogachek, M., Vakhrushev, I., Makarevich, P., and Richter, V. (2026). Heterotypic 3D Model of Breast Cancer Based on Tumor, Stromal and Endothelial Cells: Cytokines Interaction in the Tumor Microenvironment. Cells, 15.","DOI":"10.3390\/cells15020145"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semcancer.2025.02.013","article-title":"Epithelial-Mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis","volume":"112","author":"Guo","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Pisanu, M.E., Iorio, E., Facchiano, F., Chirico, M., Scattoni, M.L., and Tabolacci, C. (2026). Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27041715"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","article-title":"ACSL4 and Polyunsaturated Lipids Support Metastatic Extravasation and Colonization","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","article-title":"Ferroptosis Assassinates Tumor","volume":"20","author":"Luo","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"122458","DOI":"10.1016\/j.biomaterials.2023.122458","article-title":"Ultrasound-Enhanced Nano Catalyst with Ferroptosis-Apoptosis Combined Anticancer Strategy for Metastatic Uveal Melanoma","volume":"305","author":"Wang","year":"2024","journal-title":"Biomaterials"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41420-023-01446-6","article-title":"Patient-Derived Zebrafish Xenografts of Uveal Melanoma Reveal Ferroptosis as a Drug Target","volume":"9","author":"Groenewoud","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Swords, E., Kennedy, B.N., and Tonelotto, V. (2024). Assessment of Ferroptosis as a Promising Candidate for Metastatic Uveal Melanoma Treatment and Prognostication. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1466896"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41419-019-2143-7","article-title":"Aldo-Keto Reductases Protect Metastatic Melanoma from ER Stress-Independent Ferroptosis","volume":"10","author":"Gagliardi","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-025-09709-1","article-title":"Lymph Node Environment Drives FSP1 Targetability in Metastasizing Melanoma","volume":"649","author":"Palma","year":"2026","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"eadp6164","DOI":"10.1126\/sciadv.adp6164","article-title":"Secreted Apoe Rewires Melanoma Cell State Vulnerability to Ferroptosis","volume":"10","author":"More","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/2159-8290.CD-19-1500","article-title":"The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis","volume":"11","author":"Hong","year":"2021","journal-title":"Cancer Discov."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"152900","DOI":"10.1016\/j.imbio.2025.152900","article-title":"APOE Modulates Ferroptosis to Drive Macrophage Polarization toward the M2 Type and Enhance PTC Migration and Invasion","volume":"230","author":"Li","year":"2025","journal-title":"Immunobiology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","article-title":"TGF-\u03921-Mediated Repression of SLC7A11 Drives Vulnerability to GPX4 Inhibition in Hepatocellular Carcinoma Cells","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13046-022-02493-0","article-title":"AADAC Protects Colorectal Cancer Liver Colonization from Ferroptosis through SLC7A11-Dependent Inhibition of Lipid Peroxidation","volume":"41","author":"Sun","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13062-024-00511-z","article-title":"METTL3 in Cancer-Associated Fibroblasts-Derived Exosomes Promotes the Proliferation and Metastasis and Suppresses Ferroptosis in Colorectal Cancer by Eliciting ACSL3 M6A Modification","volume":"19","author":"Ren","year":"2024","journal-title":"Biol. Direct"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Yu, Z., Tong, S., Wang, C., Wu, Z., Ye, Y., Wang, S., and Jiang, K. (2022). PPy@Fe3O4 Nanoparticles Inhibit the Proliferation and Metastasis of CRC via Suppressing the NF-KB Signaling Pathway and Promoting Ferroptosis. Front. Bioeng. Biotechnol., 10, Erratum in Front. Bioeng. Biotechnol.\u00a02022, 10, 1094064. https:\/\/doi.org\/10.3389\/fbioe.2022.1094064. Erratum in Front. Bioeng. Biotechnol.\u00a02023, 11, 1148674. https:\/\/doi.org\/10.3389\/fbioe.2023.1148674.","DOI":"10.3389\/fbioe.2022.1001994"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Ni, S., Zhuge, A., Li, B., and Li, L. (2021). Iron Regulates the Warburg Effect and Ferroptosis in Colorectal Cancer. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.614778"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12935-024-03260-1","article-title":"The Clustering Status of Detached Gastric Cancer Cells Inhibits Anoikis-Induced Ferroptosis to Promote Metastatic Colonization","volume":"24","author":"Sun","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1007\/s11010-025-05354-4","article-title":"LINC02266 Promotes Proliferation and Metastasis and Inhibits Ferroptosis of Gastric Cancer Cells by Regulating AKT\/ACSL4 Pathway","volume":"480","author":"Liang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/10715762.2025.2515202","article-title":"Dioscin Induces Ferroptosis to Suppress the Metastasis of Gastric Cancer through the SLC7A11\/GPX4 Axis","volume":"59","author":"Lu","year":"2025","journal-title":"Free Radic. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"e33674","DOI":"10.1016\/j.heliyon.2024.e33674","article-title":"Induction of Ferroptosis by Brucine Suppresses Gastric Cancer Progression through the P53-Mediated SLCA711\/ALOX12 Axis","volume":"10","author":"Zhai","year":"2024","journal-title":"Heliyon"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"103964","DOI":"10.1016\/j.critrevonc.2023.103964","article-title":"Epithelial-Mesenchymal Plasticity: Implications for Ferroptosis Vulnerability and Cancer Therapy","volume":"185","author":"Lee","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3892\/ijmm.2022.5140","article-title":"Starvation Mediates Pancreatic Cancer Cell Sensitivity to Ferroptosis via ERK1\/2, JNK and Changes in the Cell Mesenchymal State","volume":"49","author":"Zalyte","year":"2022","journal-title":"Int. J. Mol. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3934\/genet.2017.2.103","article-title":"DNA Damage by Lipid Peroxidation Products: Implications in Cancer, Inflammation and Autoimmunity","volume":"4","author":"Gentile","year":"2017","journal-title":"AIMS Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.freeradbiomed.2016.12.025","article-title":"4-Hydroxynonenal Metabolites and Adducts in Pre-Carcinogenic Conditions and Cancer","volume":"111","year":"2017","journal-title":"Free Radic. Biol. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"103719","DOI":"10.1016\/j.redox.2025.103719","article-title":"Immunomodulatory Effects of 4-Hydroxynonenal","volume":"85","author":"Ioannidis","year":"2025","journal-title":"Redox Biol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","article-title":"Ferroptotic Damage Promotes Pancreatic Tumorigenesis through a TMEM173\/STING-Dependent DNA Sensor Pathway","volume":"11","author":"Dai","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.trecan.2021.04.005","article-title":"Targeting Ferroptosis in Pancreatic Cancer: A Double-Edged Sword","volume":"7","author":"Chen","year":"2021","journal-title":"Trends Cancer"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1868691","DOI":"10.1080\/2162402X.2020.1868691","article-title":"The Dark Side of Ferroptosis in Pancreatic Cancer","volume":"10","author":"Liu","year":"2021","journal-title":"Oncoimmunology"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s42003-025-08776-4","article-title":"A-to-I Edited SNHG3 Promotes Non-Small Cell Lung Cancer Metastasis by Promoting Fatty Acid Oxidation and Resisting Ferroptosis","volume":"8","author":"Chen","year":"2025","journal-title":"Commun. Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1158\/0008-5472.CAN-06-3137","article-title":"Adaptation of Energy Metabolism in Breast Cancer Brain Metastases","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.3390\/ijms15069519","article-title":"Molecular Biology of Brain Metastasis","volume":"15","author":"Svokos","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1002\/ctm2.517","article-title":"Glutathione Peroxidase 4-dependent Glutathione High-consumption Drives Acquired Platinum Chemoresistance in Lung Cancer-derived Brain Metastasis","volume":"11","author":"Liu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13058-019-1177-1","article-title":"Neoadjuvant Neratinib Promotes Ferroptosis and Inhibits Brain Metastasis in a Novel Syngeneic Model of Spontaneous HER2+ve Breast Cancer Metastasis","volume":"21","author":"Nagpal","year":"2019","journal-title":"Breast Cancer Res."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Jeney, V. (2017). Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss. Front. Pharmacol., 8.","DOI":"10.3389\/fphar.2017.00077"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"von Brackel, F.N., and Oheim, R. (2024). Iron and Bones: Effects of Iron Overload, Deficiency and Anemia Treatments on Bone. JBMR Plus, 8.","DOI":"10.1093\/jbmrpl\/ziae064"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Ciosek, \u017b., Kot, K., and Rotter, I. (2023). Iron, Zinc, Copper, Cadmium, Mercury, and Bone Tissue. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20032197"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"36544","DOI":"10.1021\/acsnano.5c11563","article-title":"A Therapeutic System Regulating Iron Metabolism in CD63 + Macrophage Subsets Activates Anti-Tumor Immunity for Bone Metastasis Therapy","volume":"19","author":"Xue","year":"2025","journal-title":"ACS Nano"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"e39158","DOI":"10.1097\/MD.0000000000039158","article-title":"Ferroptosis: Regulatory Mechanisms and Potential Targets for Bone Metabolism: A Review","volume":"103","author":"Zhang","year":"2024","journal-title":"Medicine"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Xiao, R., Han, Z., Jia, P., Li, P., Gong, M., Cai, Y., Pang, L., Ye, X., and Jin, S. (2025). Ferroptosis and Bone Health: Bridging the Gap between Mechanisms and Therapy. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1634516"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-025-02544-y","article-title":"Ferroptosis and Metastasis: Molecular Checkpoints, Microenvironmental Dynamics, and Therapeutic Opportunities","volume":"25","author":"Guo","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41413-024-00384-y","article-title":"Melanoma Bone Metastasis-Induced Osteocyte Ferroptosis via the HIF1\u03b1-HMOX1 Axis","volume":"13","author":"Jia","year":"2025","journal-title":"Bone Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s40001-025-03800-z","article-title":"The Iron\u2013Ferroptosis Axis in Bone Homeostasis: A Potential Complementary Pathway for Osteoporosis in Endometriosis","volume":"31","author":"Motafeghi","year":"2026","journal-title":"Eur. J. Med. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3892\/ijmm.2024.5480","article-title":"Iron Metabolism and the Tumor Microenvironment: A New Perspective on Cancer Intervention and Therapy (Review)","volume":"55","author":"Bu","year":"2024","journal-title":"Int. J. Mol. Med."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Han, Y., Sarkar, H., Xu, Z., Lopez-Darwin, S., Wei, Y., Hang, X., Liu, F., Tran, K., Wang, W., and Miller, J.M. (2025). Niche Macrophages Recycle Iron to Tumor Cells and Foster Erythroblast Mimicry to Promote Bone Metastasis and Anemia. bioRxiv.","DOI":"10.1101\/2025.04.23.650120"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"114847","DOI":"10.1016\/j.yexcr.2025.114847","article-title":"Ferroptosis Modulates Invasion and Migration in Prostate Cancer PC-3M Subclones","volume":"454","author":"Rao","year":"2026","journal-title":"Exp. Cell Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"PR002","DOI":"10.1158\/1538-7755.DISP23-PR002","article-title":"Abstract PR002: Ferroptosis Inducers Can Antagonize Prostate Cancer-Bone Interactions","volume":"32","author":"Dike","year":"2023","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-024-00869-9","article-title":"Unlocking Ferroptosis in Prostate Cancer \u2014 the Road to Novel Therapies and Imaging Markers","volume":"21","author":"Cao","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"108473","DOI":"10.1016\/j.jbc.2025.108473","article-title":"Tissue Inhibitor of Metalloproteinase 1 Promotes Ferroptosis and Suppresses Prostate Cancer Metastasis","volume":"301","author":"Rao","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Liu, X., Zhang, Y., Wu, X., Xu, F., Ma, H., Wu, M., and Xia, Y. (2022). Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.909821"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1471-0528.17327","article-title":"High Co-expression of SLC7A11 and GPX4 as a Predictor of Platinum Resistance and Poor Prognosis in Patients with Epithelial Ovarian Cancer","volume":"129","author":"Wu","year":"2022","journal-title":"BJOG"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"863","DOI":"10.32604\/or.2024.054201","article-title":"The Role of Glutathione Peroxidase 4 in the Progression, Drug Resistance, and Targeted Therapy of Non-Small Cell Lung Cancer","volume":"33","author":"WEI","year":"2025","journal-title":"Oncol. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","article-title":"The Regulation and Function of Nrf2 Signaling in Ferroptosis-Activated Cancer Therapy","volume":"45","author":"Jiang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Lee, J., Seo, Y., and Roh, J.-L. (2025). Ferroptosis and Nrf2 Signaling in Head and Neck Cancer: Resistance Mechanisms and Therapeutic Prospects. Antioxidants, 14.","DOI":"10.3390\/antiox14080993"},{"key":"ref_161","first-page":"40","article-title":"Corosolic Acid Increases the Therapeutic Effect of Cisplatin on Gastric Cancer by Regulating Gpx4-Dependent Ferroptosis","volume":"8","author":"Lin","year":"2025","journal-title":"Cancer Drug Resist."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41698-025-01004-6","article-title":"Targeting SIX2 as a Novel Sensitization Strategy of Sorafenib Treatment on Advanced Hepatocellular Carcinoma through Modulating METTL9-SLC7A11 Axis","volume":"9","author":"Lu","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"He, J., Li, M., Bao, J., Peng, Y., Xue, W., Chen, J., and Zhao, J. (2024). \u03b2-Elemene Promotes Ferroptosis and Reverses Radioresistance in Gastric Cancer by Inhibiting the OTUB1-GPX4 Interaction. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1469180"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.44705","article-title":"Combinative Treatment of \u03b2-Elemene and Cetuximab Is Sensitive to KRAS Mutant Colorectal Cancer Cells by Inducing Ferroptosis and Inhibiting Epithelial-Mesenchymal Transformation","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1007\/s00432-023-04811-1","article-title":"Apatinib Combined with Olaparib Induces Ferroptosis via a P53-Dependent Manner in Ovarian Cancer","volume":"149","author":"Yue","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41420-025-02309-y","article-title":"SPHK1 Enhances Olaparib Resistance in Ovarian Cancer through the NF\u03baB\/NRF2\/Ferroptosis Pathway","volume":"11","author":"Teng","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"101928","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP Inhibition Promotes Ferroptosis via Repressing SLC7A11 and Synergizes with Ferroptosis Inducers in BRCA-Proficient Ovarian Cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 Triggers Ferroptosis in Lung Cancer","volume":"649","author":"Wu","year":"2026","journal-title":"Nature"},{"key":"ref_169","first-page":"627","article-title":"Targeting of FSP1 Regulates Iron Homeostasis in Drug-Tolerant Persister Head and Neck Cancer Cells via Lipid-Metabolism-Driven Ferroptosis","volume":"16","author":"Wu","year":"2024","journal-title":"Aging"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Tahsin, T., McPhail, D.K., Champion, J.D., Alzahrani, M.A.M., Hilditch, M.L., Faris-Orr, A., Calver, B.L., Cronin, J.G., Mareque-Rivas, J.C., and Sexton, D.W. (2025). Targeting NRF2 and FSP1 to Overcome Ferroptosis Resistance in TSC2-Deficient and Cancer Cells. Cancers, 17.","DOI":"10.20944\/preprints202504.0343.v1"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Lee, N., Carlisle, A.E., Peppers, A., Park, S.J., Doshi, M.B., Spears, M.E., and Kim, D. (2021). XCT-Driven Expression of GPX4 Determines Sensitivity of Breast Cancer Cells to Ferroptosis Inducers. Antioxidants, 10.","DOI":"10.3390\/antiox10020317"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Lin, Y., Cai, H., and Zhou, T. (2025). EZH2 Confers Lenvatinib Resistance in Hepatocellular Carcinoma by Suppressing ACSL1-Mediated Ferroptosis. BMC Cancer, 25.","DOI":"10.1186\/s12885-025-15086-9"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1038\/s41467-025-65056-9","article-title":"Co-Delivery of Sorafenib and an FSP1 Inhibitor Triggers Dual Ferroptosis in Tumor Cells and Immunosuppressive Macrophages for Enhanced Immunotherapy in Mouse Models of Hepatocellular Carcinoma","volume":"16","author":"Tang","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Guo, L., Hu, C., Yao, M., and Han, G. (2023). Mechanism of Sorafenib Resistance Associated with Ferroptosis in HCC. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1207496"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.devcel.2019.10.007","article-title":"Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export","volume":"51","author":"Brown","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature24637","article-title":"NFS1 Undergoes Positive Selection in Lung Tumours and Protects Cells from Ferroptosis","volume":"551","author":"Alvarez","year":"2017","journal-title":"Nature"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2018.06.018","article-title":"CISD2 Inhibition Overcomes Resistance to Sulfasalazine-Induced Ferroptotic Cell Death in Head and Neck Cancer","volume":"432","author":"Kim","year":"2018","journal-title":"Cancer Lett."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"101483","DOI":"10.1016\/j.redox.2020.101483","article-title":"Identification of Frataxin as a Regulator of Ferroptosis","volume":"32","author":"Du","year":"2020","journal-title":"Redox Biol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Loftus, L.V., Rolle, L.T.A., Wang, B., Pienta, K.J., and Amend, S.R. (2025). Dysregulation of Labile Iron Predisposes Chemotherapy Resistant Cancer Cells to Ferroptosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26094193"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12943-024-02198-2","article-title":"Cancer Cells Avoid Ferroptosis Induced by Immune Cells via Fatty Acid Binding Proteins","volume":"24","author":"Masrorpour","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Cruz-Gregorio, A., and Aranda-Rivera, A.K. (2023). Quercetin and Ferroptosis. Life, 13.","DOI":"10.3390\/life13081730"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/1759-7714.13904","article-title":"Curcumin Induces Ferroptosis in Non-small-cell Lung Cancer via Activating Autophagy","volume":"12","author":"Tang","year":"2021","journal-title":"Thorac. Cancer"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"113004","DOI":"10.1016\/j.inoche.2024.113004","article-title":"Glucose-Capped Fisetin Silver Nanoparticles Induced Cytotoxicity and Ferroptosis in Breast Cancer Cells: A Molecular Perspective","volume":"169","author":"Subhalakshmi","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2021.02.126","article-title":"Vitamin C Induces Ferroptosis in Anaplastic Thyroid Cancer Cells by Ferritinophagy Activation","volume":"551","author":"Wang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/10715762.2024.2320396","article-title":"Ascorbic Acid Induces Ferroptosis via STAT3\/GPX4 Signaling in Oropharyngeal Cancer","volume":"58","author":"Wu","year":"2024","journal-title":"Free Radic. Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in Cancer: From Molecular Mechanisms to Therapeutic Strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Zou, J., Wang, L., Tang, H., Liu, X., Peng, F., and Peng, C. (2021). Ferroptosis in Non-Small Cell Lung Cancer: Progression and Therapeutic Potential on It. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222413335"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023049084","article-title":"TFR1-Mediated Iron Metabolism Orchestrates Tumor Ferroptosis and Immunity in Non-Small Cell Lung Cancer","volume":"43","author":"Wang","year":"2024","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12032-025-02757-7","article-title":"Iron Overload Enhances the Susceptibility to Cysteine Deprivation-Induced Ferroptosis in Non-Small Cell Lung Cancer Cells","volume":"42","author":"Kim","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"110262","DOI":"10.1016\/j.cbi.2022.110262","article-title":"Trabectedin Induces Ferroptosis via Regulation of HIF-1\u03b1\/IRP1\/TFR1 and Keap1\/Nrf2\/GPX4 Axis in Non-Small Cell Lung Cancer Cells","volume":"369","author":"Cai","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Lei, Y., Jiang, S., Kong, C., Pang, P., and Shan, H. (2025). Ferroptosis: Therapeutic Potential and Strategies in Non-Small Cell Lung Cancer. Biology, 14.","DOI":"10.3390\/biology14050545"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Zhao, H., Ao, L., Wei, Y., Yin, H.Z., Zhang, N., Lee, X.Q., Du, F.L., and Zhou, G.L. (2025). Ferroptosis and Gastric Cancer: From Molecular Mechanisms to Clinical Implications. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1581928"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11658-021-00271-y","article-title":"Induction of Ferroptosis by ATF3 Elevation Alleviates Cisplatin Resistance in Gastric Cancer by Restraining Nrf2\/Keap1\/XCT Signaling","volume":"26","author":"Fu","year":"2021","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/CEJ.0000000000000817","article-title":"The Putative Role of Ferroptosis in Gastric Cancer: A Review","volume":"32","author":"Wang","year":"2023","journal-title":"Eur. J. Cancer Prev."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.62347\/KSKH3925","article-title":"Targeting Ferroptosis and Immune Surveillance in Gastric Cancer with Traditional Chinese Medicine Monomers: A Dual-Targeted Strategy for Epithelial-Mesenchymal Transition and Angiogenesis","volume":"15","author":"Ma","year":"2025","journal-title":"Am. J. Cancer Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s10495-023-01891-9","article-title":"Advancing the Frontiers of Colorectal Cancer Treatment: Harnessing Ferroptosis Regulation","volume":"29","author":"Liu","year":"2024","journal-title":"Apoptosis"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/CMAR.S274631","article-title":"Apatinib Promotes Ferroptosis in Colorectal Cancer Cells by Targeting ELOVL6\/ACSL4 Signaling","volume":"13","author":"Tian","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"157470","DOI":"10.1016\/j.phymed.2025.157470","article-title":"Andrographolide Induces Ferroptosis in Colorectal Cancer via P53-Mediated Downregulation of the SLC7A11\/GPX4 Signaling Pathway","volume":"148","author":"Wang","year":"2025","journal-title":"Phytomedicine"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","article-title":"Targeting FTO Induces Colorectal Cancer Ferroptotic Cell Death by Decreasing SLC7A11\/GPX4 Expression","volume":"43","author":"Qiao","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/CMAR.S483526","article-title":"The High Expression of SLC7A11 and GPX4 Are Significantly Correlated with \u03b2-Catenin in Colorectal Cancer","volume":"16","author":"Ou","year":"2024","journal-title":"Cancer Manag. Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41420-025-02744-x","article-title":"Harnessing Ferroptosis to Transform Glioblastoma Therapy and Surmount Treatment Resistance","volume":"11","author":"Singh","year":"2025","journal-title":"Cell Death Discov."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41419-024-06558-0","article-title":"Targeting SIRT3 Sensitizes Glioblastoma to Ferroptosis by Promoting Mitophagy and Inhibiting SLC7A11","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41419-023-05738-8","article-title":"Fatostatin Induces Ferroptosis through Inhibition of the AKT\/MTORC1\/GPX4 Signaling Pathway in Glioblastoma","volume":"14","author":"Cai","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"21259","DOI":"10.1038\/s41598-025-05866-5","article-title":"SLC10A3 Regulates Ferroptosis of Glioblastoma through the STAT3\/GPX4 Pathway","volume":"15","author":"Sun","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"107992","DOI":"10.1016\/j.pharmthera.2021.107992","article-title":"Emerging Role of Ferroptosis in Breast Cancer: New Dawn for Overcoming Tumor Progression","volume":"232","author":"Sui","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"103480","DOI":"10.1016\/j.redox.2024.103480","article-title":"De Novo Lipogenesis Protects Dormant Breast Cancer Cells from Ferroptosis and Promotes Metastasis","volume":"80","author":"Esteo","year":"2025","journal-title":"Redox Biol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41418-022-00998-x","article-title":"Non-Coding RNAs and Ferroptosis: Potential Implications for Cancer Therapy","volume":"29","author":"Balihodzic","year":"2022","journal-title":"Cell Death Differ."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13045-022-01297-1","article-title":"Mammary Adipocytes Protect Triple-Negative Breast Cancer Cells from Ferroptosis","volume":"15","author":"Xie","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_209","first-page":"606","article-title":"ACSL3 Regulates Breast Cancer Progression via Lipid Metabolism Reprogramming and the YES1\/YAP Axis","volume":"21","author":"Tan","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Lyu, H., Kong, J., Chen, J., Zhang, R., Xiao, S., Guo, D., Zhang, Q., Chen, X.-Z., Tang, J., and Zhou, C. (2024). The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413334"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Ruiz, C.F., Ge, X., McDonnell, R., Agabiti, S.S., McQuaid, D.C., Tang, A., Kharwa, M., Goodell, J., Saavedra-Pe\u00f1a, R.d.M., and Wing, A. (2025). Diet-Induced Phospholipid Remodeling Dictates Ferroptosis Sensitivity and Tumorigenesis in the Pancreas. bioRxiv.","DOI":"10.1101\/2025.04.04.645324"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1038\/s41598-024-55050-4","article-title":"Polyunsaturated Fatty Acids-Induced Ferroptosis Suppresses Pancreatic Cancer Growth","volume":"14","author":"Suda","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.chembiol.2024.09.008","article-title":"Lipid Availability Influences Ferroptosis Sensitivity in Cancer Cells by Regulating Polyunsaturated Fatty Acid Trafficking","volume":"32","author":"Sokol","year":"2025","journal-title":"Cell Chem. Biol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.7150\/jca.114356","article-title":"SREBP1-SCD1 Enhanced MUFAs Biosynthesis Drives Nutrient Deprived Pancreatic Cancer Cell Ferroptosis Resistance","volume":"16","author":"Zhang","year":"2025","journal-title":"J. Cancer"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Guo, K., Lu, M., Bi, J., Yao, T., Gao, J., Ren, F., and Zhu, L. (2024). Ferroptosis: Mechanism, Immunotherapy and Role in Ovarian Cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1410018"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"103350","DOI":"10.1016\/j.redox.2024.103350","article-title":"Targeting GPX4-Mediated Ferroptosis Protection Sensitizes BRCA1-Deficient Cancer Cells to PARP Inhibitors","volume":"76","author":"Xie","year":"2024","journal-title":"Redox Biol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in Hepatocellular Carcinoma: Mechanisms and Targeted Therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"e0246","DOI":"10.1097\/HC9.0000000000000246","article-title":"Sorafenib Induces Ferroptosis by Promoting TRIM54-Mediated FSP1 Ubiquitination and Degradation in Hepatocellular Carcinoma","volume":"7","author":"Liu","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmgh.2023.03.001","article-title":"Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-Tumor Immune Responses in Liver Cancer","volume":"16","author":"Cheu","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Jiang, Y., Yu, Y., Pan, Z., Wang, Z., and Sun, M. (2024). Ginsenoside RK1 Induces Ferroptosis in Hepatocellular Carcinoma Cells through an FSP1-Dependent Pathway. Pharmaceuticals, 17.","DOI":"10.3390\/ph17070871"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"e14351","DOI":"10.15252\/emmm.202114351","article-title":"YAP\/TAZ and ATF4 Drive Resistance to Sorafenib in Hepatocellular Carcinoma by Preventing Ferroptosis","volume":"13","author":"Gao","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jid.2024.11.007","article-title":"Ferroptosis: A Targetable Vulnerability for Melanoma Treatment","volume":"145","author":"Meng","year":"2025","journal-title":"J. Investig. Dermatol."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"114034","DOI":"10.1016\/j.yexcr.2024.114034","article-title":"Salidroside Induces Mitochondrial Dysfunction and Ferroptosis to Inhibit Melanoma Progression through Reactive Oxygen Species Production","volume":"438","author":"Zhang","year":"2024","journal-title":"Exp. Cell Res."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1038\/s41467-025-66113-z","article-title":"AMP-Activated Protein Kinase-Driven Lipid Droplet Dynamics Govern Melanoma Sensitivity to Polyunsaturated Fatty Acid and Iron-Induced Ferroptosis","volume":"16","author":"Motamedi","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"e009805","DOI":"10.1136\/jitc-2024-009805","article-title":"Propafenone Facilitates Mitochondrial-Associated Ferroptosis and Synergizes with Immunotherapy in Melanoma","volume":"12","author":"Zhou","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Mynott, R.L., Habib, A., Best, O.G., and Wallington-Gates, C.T. (2023). Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087661"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s40001-024-01822-7","article-title":"Targeting Ferroptosis for Leukemia Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Leukemia Based on Nanotechnology","volume":"29","author":"Ashoub","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Reikvam, H., Rolfsnes, M.G., Rolsdorph, L., Sandnes, M., Selheim, F., Hernandez-Valladares, M., and Bruserud, \u00d8. (2025). Ferritin in Acute Myeloid Leukemia: Not Only a Marker of Inflammation and Iron Overload, but Also a Regulator of Cellular Iron Metabolism, Signaling and Communication. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125744"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"e1054549","DOI":"10.1080\/23723556.2015.1054549","article-title":"The Ferroptosis Inducer Erastin Enhances Sensitivity of Acute Myeloid Leukemia Cells to Chemotherapeutic Agents","volume":"2","author":"Yu","year":"2015","journal-title":"Mol. Cell. Oncol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of Ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41392-022-01046-3","article-title":"Autophagy, Ferroptosis, Pyroptosis, and Necroptosis in Tumor Immunotherapy","volume":"7","author":"Gao","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41598-018-37408-7","article-title":"Imaging Endogenous Macrophage Iron Deposits Reveals a Metabolic Biomarker of Polarized Tumor Macrophage Infiltration and Response to CSF1R Breast Cancer Immunotherapy","volume":"9","author":"Leftin","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"e3712","DOI":"10.1002\/nbm.3712","article-title":"Inhibition of Prostate Cancer Proliferation by Deferiprone","volume":"30","author":"Veeraperumal","year":"2017","journal-title":"NMR Biomed."},{"key":"ref_234","doi-asserted-by":"crossref","unstructured":"Leftin, A., Ben-Chetrit, N., Klemm, F., Joyce, J.A., and Koutcher, J.A. (2017). Iron Imaging Reveals Tumor and Metastasis Macrophage Hemosiderin Deposits in Breast Cancer. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184765"},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"Mertens, C., Akam, E.A., Rehwald, C., Br\u00fcne, B., Tomat, E., and Jung, M. (2016). Intracellular Iron Chelation Modulates the Macrophage Iron Phenotype with Consequences on Tumor Progression. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0166164"},{"key":"ref_236","first-page":"35","article-title":"Impaired Erythropoietin Responsiveness to the Anaemia in Rheumatoid Arthritis. A Possible Inverse Relationship with Iron Stores and Effects of the Oral Iron Chelator 1,2-Dimethyl-3-Hydroxypyrid-4-One","volume":"9","author":"Vreugdenhil","year":"1991","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(89)92011-4","article-title":"Efficacy and Safety of Oral Iron Chelator L1 in Anaemic Rheumatoid Arthritis Patients","volume":"334","author":"Vreugdenhil","year":"1989","journal-title":"Lancet"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajh.2830340106","article-title":"Effect of Novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one Chelators on Uptake and Release of Iron from Macrophages","volume":"34","author":"Brock","year":"1990","journal-title":"Am. J. Hematol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1600-0609.2010.01499.x","article-title":"Reduction of Body Iron Stores to Normal Range Levels in Thalassaemia by Using a Deferiprone\/Deferoxamine Combination and Their Maintenance Thereafter by Deferiprone Monotherapy","volume":"85","author":"Kolnagou","year":"2010","journal-title":"Eur. J. Haematol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","article-title":"Normalisation of Total Body Iron Load with Very Intensive Combined Chelation Reverses Cardiac and Endocrine Complications of Thalassaemia Major","volume":"148","author":"Farmaki","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0043-102691","article-title":"Prevention of Iron Overload and Long Term Maintenance of Normal Iron Stores in Thalassaemia Major Patients Using Deferiprone or Deferiprone Deferoxamine Combination","volume":"67","author":"Kolnagou","year":"2017","journal-title":"Drug Res."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15376516.2012.730558","article-title":"Effect of Deferiprone, an Oral Iron Chelator, in Diabetic and Non-Diabetic Glomerular Disease","volume":"23","author":"Rajapurkar","year":"2013","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Saxena, D., Spino, M., Tricta, F., Connelly, J., Cracchiolo, B.M., Hanauske, A.R., D\u2019Alliessi Gandolfi, D., Mathews, M.B., Karn, J., and Holland, B. (2016). Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154842"},{"key":"ref_244","first-page":"17","article-title":"Deferiprone (L1) as an Adjuvant Therapy for Plasmodium Falciparum Malaria","volume":"115","author":"Mohanty","year":"2002","journal-title":"Indian J. Med. Res."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1159\/000535749","article-title":"The Effect of Oral Iron Chelator Deferiprone on Iron Overload and Oxidative Stress in Patients with Myelodysplastic Syndromes: A Study by the Israeli MDS Working Group","volume":"147","author":"Merkel","year":"2024","journal-title":"Acta Haematol."},{"key":"ref_246","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2023). Drug Selection and Posology, Optimal Therapies and Risk\/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242316749"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G.J. (2025). Development of Iron-Chelating\/Antioxidant Nutraceuticals and Natural Products as Pharmaceuticals for Clinical Use in Diseases with Free Radical Pathologies. Nutrients, 17.","DOI":"10.3390\/nu17203270"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2147\/DDDT.S79458","article-title":"Efficacy and Safety of Iron-Chelation Therapy with Deferoxamine, Deferiprone, and Deferasirox for the Treatment of Iron-Loaded Patients with Non-Transfusion-Dependent Thalassemia Syndromes","volume":"10","author":"Kontoghiorghes","year":"2016","journal-title":"Drug Des. Devel. Ther."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Kontoghiorghes, G., and Kontoghiorghe, C. (2020). Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells, 9.","DOI":"10.3390\/cells9061456"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1158\/0008-5472.CAN-13-0474","article-title":"Blocking EIF5A Modification in Cervical Cancer Cells Alters the Expression of Cancer-Related Genes and Suppresses Cell Proliferation","volume":"74","author":"Hoque","year":"2014","journal-title":"Cancer Res."},{"key":"ref_251","first-page":"160","article-title":"Deferiprone: An In Vitro Inhibitor of Protein Hydroxylases Vital for Matrix Formation and Cell Proliferation \u2020 944","volume":"39","author":"Newfield","year":"1996","journal-title":"Pediatr. Res."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1038\/s41598-019-39214-1","article-title":"Deferiprone: Pan-Selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study","volume":"9","author":"Khodaverdian","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_253","doi-asserted-by":"crossref","unstructured":"Fiorillo, M., T\u00f3th, F., Brindisi, M., Sotgia, F., and Lisanti, M.P. (2020). Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production. Cells, 9.","DOI":"10.3390\/cells9061529"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/gutjnl-2024-333255","article-title":"Role of CNNM4 in the Progression of Cholangiocarcinoma: Implications for Ferroptosis and Therapeutic Potential","volume":"75","author":"Afonso","year":"2026","journal-title":"Gut"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.3390\/ph3072322","article-title":"Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria","volume":"3","author":"Li","year":"2010","journal-title":"Pharmaceuticals"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"vii80","DOI":"10.1093\/neuonc\/noac209.305","article-title":"CTNI-40. Phase I Trial of Sulfasalazine Combined with Stereotactic Radiosurgery for Recurrent Glioblastoma: Study Protocol For NCT04205357","volume":"24","author":"Skeie","year":"2022","journal-title":"Neuro-Oncology"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"101250","DOI":"10.1016\/j.drup.2025.101250","article-title":"Targeting SLC7A11 with Sorafenib Sensitizes Stereotactic Body Radiotherapy in Colorectal Cancer Liver Metastasis","volume":"81","author":"He","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Dai, D., Chen, C., Lu, C., Guo, Y., Li, Q., and Sun, C. (2024). Apoptosis, Autophagy, Ferroptosis, and Pyroptosis in Cisplatin-Induced Ototoxicity and Protective Agents. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1430469"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"106939","DOI":"10.1016\/j.ejps.2024.106939","article-title":"Advances in Understanding Cisplatin-Induced Toxicity: Molecular Mechanisms and Protective Strategies","volume":"203","author":"Elmorsy","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s43018-023-00653-5","article-title":"Imetelstat-Mediated Alterations in Fatty Acid Metabolism to Induce Ferroptosis as a Therapeutic Strategy for Acute Myeloid Leukemia","volume":"5","author":"Bruedigam","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00280-024-04742-9","article-title":"A Phase I Study of MLN4924 and Belinostat in Relapsed\/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome","volume":"95","author":"Maher","year":"2025","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"101287","DOI":"10.1016\/j.tjnut.2025.101287","article-title":"Pesco-Vegetarian Food Components Promote Colonocyte Ferroptosis in Preclinical Mouse Models and a Randomized Crossover Trial in Healthy Human Adults","volume":"156","author":"Fan","year":"2026","journal-title":"J. Nutr."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.freeradbiomed.2024.01.002","article-title":"Quercetin Induces Ferroptosis in Gastric Cancer Cells by Targeting SLC1A5 and Regulating the P-Camk2\/p-DRP1 and NRF2\/GPX4 Axes","volume":"213","author":"Ding","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"ref_264","doi-asserted-by":"crossref","unstructured":"Li, D., Liu, X., Pi, W., Zhang, Y., Yu, L., Xu, C., Sun, Z., and Jiang, J. (2022). Fisetin Attenuates Doxorubicin-Induced Cardiomyopathy In Vivo and In Vitro by Inhibiting Ferroptosis Through SIRT1\/Nrf2 Signaling Pathway Activation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.808480"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1053\/j.seminoncol.2017.10.001","article-title":"Pilot Study Demonstrating Metabolic and Anti-Proliferative Effects of in Vivo Anti-Oxidant Supplementation with N-Acetylcysteine in Breast Cancer","volume":"44","author":"Monti","year":"2017","journal-title":"Semin. Oncol."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"e23464","DOI":"10.1002\/jbt.23464","article-title":"Analysis of LncRNAs Profiles Associated with Ferroptosis Can Predict Prognosis and Immune Landscape and Drug Sensitivity in Patients with Clear Cell Renal Cell Carcinoma","volume":"37","author":"Zong","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Gao, C., Kong, N., Zhang, F., Tang, T., Li, J., Ding, H., Sun, Z., Wu, L., and Xu, M. (2022). Risk Stratification of Lung Adenocarcinoma Using a Nomogram Combined with Ferroptosis-Related LncRNAs and Subgroup Analysis with Immune and N6-Methyladenosine Modification. BMC Med. Genom., 15.","DOI":"10.1186\/s12920-022-01164-5"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"6284540","DOI":"10.1155\/2022\/6284540","article-title":"A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma","volume":"2022","author":"Lian","year":"2022","journal-title":"Comput. Math. Methods Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1436\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:15:07Z","timestamp":1778386507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/9\/1436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":268,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["cancers18091436"],"URL":"https:\/\/doi.org\/10.3390\/cancers18091436","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]}}}